HK1202923A1 - Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject 5t4 5t4 - Google Patents

Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject 5t4 5t4

Info

Publication number
HK1202923A1
HK1202923A1 HK15103408.3A HK15103408A HK1202923A1 HK 1202923 A1 HK1202923 A1 HK 1202923A1 HK 15103408 A HK15103408 A HK 15103408A HK 1202923 A1 HK1202923 A1 HK 1202923A1
Authority
HK
Hong Kong
Prior art keywords
methods
positive
diagnosis
detecting
tumor cells
Prior art date
Application number
HK15103408.3A
Other languages
English (en)
Chinese (zh)
Inventor
‧格貝爾
‧馬里努奇
‧皮里謝潑德
‧塔克
Original Assignee
Pfizer
Epic Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Epic Sciences Inc filed Critical Pfizer
Publication of HK1202923A1 publication Critical patent/HK1202923A1/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70589CD45

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
HK15103408.3A 2012-01-24 2015-04-08 Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject 5t4 5t4 HK1202923A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261590066P 2012-01-24 2012-01-24
US201361753665P 2013-01-17 2013-01-17
PCT/IB2013/050547 WO2013111054A1 (fr) 2012-01-24 2013-01-22 Méthodes de détection de cellules tumorales circulantes 5t4-positives et méthodes de diagnostic d'un cancer 5t4-positif chez un sujet mammifère

Publications (1)

Publication Number Publication Date
HK1202923A1 true HK1202923A1 (en) 2015-10-09

Family

ID=47844410

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103408.3A HK1202923A1 (en) 2012-01-24 2015-04-08 Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject 5t4 5t4

Country Status (15)

Country Link
US (1) US10254286B2 (fr)
EP (1) EP2807485B1 (fr)
JP (1) JP6254951B2 (fr)
KR (1) KR101716555B1 (fr)
CN (1) CN104094116B (fr)
AU (2) AU2013213301A1 (fr)
BR (1) BR112014018192A8 (fr)
CA (1) CA2861437C (fr)
ES (1) ES2724232T3 (fr)
HK (1) HK1202923A1 (fr)
IL (1) IL233543B (fr)
IN (1) IN2014DN07019A (fr)
MX (1) MX361058B (fr)
RU (1) RU2646498C2 (fr)
WO (1) WO2013111054A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107422127A (zh) 2009-10-21 2017-12-01 斯克里普斯研究所 用非稀有细胞检测稀有细胞的方法
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2015103039A1 (fr) * 2013-12-30 2015-07-09 The Scripps Research Institute Diagnostics de cellules tumorales circulantes pour un cancer du poumon
EA201691496A1 (ru) 2014-01-27 2016-12-30 Эпик Сайенсиз, Инк. Диагностика биомаркеров рака предстательной железы с помощью циркулирующих опухолевых клеток
US10545151B2 (en) * 2014-02-21 2020-01-28 Epic Sciences, Inc. Methods for analyzing rare circulating cells
WO2015155345A1 (fr) * 2014-04-11 2015-10-15 Medimmune Limited Anticorps et conjugués anticorps-médicament
EP3140656B1 (fr) * 2014-05-09 2021-02-17 The Scripps Research Institute Compositions et procédés de biopsie de liquides permettant le diagnostic de mélanome
CN107109477B (zh) * 2014-08-25 2021-01-12 创新微技术公司 在血液中的循环细胞生物标记在检测和诊断疾病中的应用及其分离方法
EP3286565A1 (fr) * 2015-04-21 2018-02-28 Genentech, Inc. Compositions et procédés pour l'analyse du cancer de la prostate
KR102406596B1 (ko) * 2016-02-23 2022-06-10 노을 주식회사 패치를 이용하는 ctc 진단 방법 및 장치
KR20170099787A (ko) * 2016-02-23 2017-09-01 노을 주식회사 표지 물질을 저장하는 패치, 이를 이용하는 조직 진단 방법 및 장치
KR20170099737A (ko) 2016-02-23 2017-09-01 노을 주식회사 접촉식 염색 패치 및 이를 이용하는 염색 방법
US10371610B2 (en) 2016-02-23 2019-08-06 Noul Co., Ltd. Contact-type patch, staining method using the same, and manufacturing method thereof
JP7247101B2 (ja) 2017-04-03 2023-03-28 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト Steap-1に結合する抗体
CN111033238A (zh) * 2017-06-27 2020-04-17 定量癌症诊断有限责任公司 定量的液体活检诊断系统与方法
CN107918013A (zh) * 2017-09-25 2018-04-17 浙江天科高新技术发展有限公司 化学发光酶免测定循环肿瘤细胞中K‑Ras蛋白的方法及试剂盒
JP2019195304A (ja) 2018-05-10 2019-11-14 学校法人順天堂 画像解析方法、装置、コンピュータプログラム、及び深層学習アルゴリズムの生成方法
US20220002429A1 (en) * 2018-10-24 2022-01-06 Northwestern University Tumor cell aggregation inhibitors' for treating cancer
JP7381003B2 (ja) * 2019-04-26 2023-11-15 学校法人順天堂 疾患解析を支援する方法、装置、及びコンピュータプログラム、並びにコンピュータアルゴリズムを訓練する方法、装置、及びプログラム
EP4445141A1 (fr) 2021-12-07 2024-10-16 Epic Sciences, Inc. Caractérisation améliorée du cancer du sein

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391904A (en) 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
EP0403559A1 (fr) 1988-03-04 1990-12-27 Cancer Research Campaign Technology Limited Ameliorations dans le domaine des antigenes
US5869053A (en) 1988-03-04 1999-02-09 Cancer Research Campaign Technology, Ltd. 5T4 antigen from human trophoblasts
ES2332435T3 (es) 1997-06-04 2010-02-04 Oxford Biomedica (Uk) Limited Vector dirigido a tumores.
JP2003515323A (ja) 1999-11-18 2003-05-07 オックスフォード バイオメディカ(ユーケイ)リミテッド 抗 体
GB0126378D0 (en) 2001-11-02 2002-01-02 Oxford Biomedica Ltd Antigen
US7305112B2 (en) 2002-10-15 2007-12-04 The Scripps Research Institute Method of converting rare cell scanner image coordinates to microscope coordinates using reticle marks on a sample media
PE20060817A1 (es) * 2004-09-10 2006-10-10 Wyeth Corp Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/calicheamicina
US20090317836A1 (en) 2006-01-30 2009-12-24 The Scripps Research Institute Methods for Detection of Circulating Tumor Cells and Methods of Diagnosis of Cancer in Mammalian Subject
KR101443752B1 (ko) 2006-03-10 2014-09-26 와이어쓰 엘엘씨 항-5t4 항체 및 이의 용도
WO2008131048A2 (fr) 2007-04-16 2008-10-30 Cellpoint Diagnotics, Inc. Dispositifs et procédés permettant de diagnostiquer, de pronostiquer ou de théranoser un état pathologique par enrichissement de cellules rares
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method
JP5923035B2 (ja) 2009-03-24 2016-05-24 バイオセプト インコーポレイティッド 細胞の捕捉および解析のデバイスおよび方法
WO2010111659A1 (fr) 2009-03-27 2010-09-30 Wyeth Llc Cellules initiatrices de tumeur et procédés pour les utiliser
AU2010289448A1 (en) 2009-09-03 2012-03-22 The Scripps Research Institute Method for categorizing circulating tumor cells
CN107422127A (zh) 2009-10-21 2017-12-01 斯克里普斯研究所 用非稀有细胞检测稀有细胞的方法
AU2011237669B2 (en) * 2010-04-06 2016-09-08 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for disease
EP3306321A1 (fr) 2010-07-07 2018-04-11 The Regents of The University of Michigan Diagnostic et traitement du cancer du sein
SI2694111T1 (sl) 2011-04-01 2016-10-28 Wyeth Llc Konjugati protitelo-zdravilo

Also Published As

Publication number Publication date
BR112014018192A8 (pt) 2021-03-02
US10254286B2 (en) 2019-04-09
ES2724232T3 (es) 2019-09-09
US20150017661A1 (en) 2015-01-15
IL233543A0 (en) 2014-08-31
MX361058B (es) 2018-11-23
CN104094116B (zh) 2017-05-31
JP2015507190A (ja) 2015-03-05
EP2807485B1 (fr) 2019-03-13
EP2807485A1 (fr) 2014-12-03
RU2646498C2 (ru) 2018-03-05
CA2861437C (fr) 2018-08-21
KR20140100580A (ko) 2014-08-14
MX2014008928A (es) 2014-10-24
CN104094116A (zh) 2014-10-08
AU2018220154A1 (en) 2018-09-13
AU2013213301A1 (en) 2014-07-17
WO2013111054A1 (fr) 2013-08-01
KR101716555B1 (ko) 2017-03-14
JP6254951B2 (ja) 2017-12-27
IN2014DN07019A (fr) 2015-04-10
RU2014127474A (ru) 2016-03-20
CA2861437A1 (fr) 2013-08-01
IL233543B (en) 2018-02-28

Similar Documents

Publication Publication Date Title
HK1202923A1 (en) Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject 5t4 5t4
IL288241A (en) Improved cell culture methods for stress cell therapy
IL271005A (en) Improved cell culture methods for stress cell therapy
HK1250350A1 (zh) 混合超聲引導的表層放射治療系統和方法
IL225646A0 (en) Methods and kits for detecting cancer cells in the circulation of pancreatic patients using polyspecific capture and cocktail detection reagents
EP3052940A4 (fr) Analyse génotypique et phénotypique de cellules tumorales circulantes permettant de surveiller l'évolution d'une tumeur chez des patients atteints de cancer de la prostate
EP2890815A4 (fr) Méthodes de diagnostic et de traitement du cancer
IL236182A0 (en) Methods for detecting diseases or conditions using circulating diseased cells
EP2847593A4 (fr) Procédés pour prédire et détecter le risque de cancer
EP2729000A4 (fr) Système pour le stockage prolongé des érythrocytes et procédés d'utilisation
GB201100180D0 (en) Tumour cell and tissue culture
EP2742123A4 (fr) Isolement et détection de cellules cancéreuses
EP2529223A4 (fr) Biomarqueurs pour cellules tumorales en circulation
IL233163A0 (en) A system and method for detecting RNA altered by cancer in peripheral blood
HK1211345A1 (en) Methods of prognosis and diagnosis of cancer
EP2733490A4 (fr) Réactif bi-fonctionnel et procédé de diagnostic de tumeur
EP2849743A4 (fr) Médicament inhibiteur de cellules cancéreuses et sonde de détection de cellules souches cancéreuses
EP2849752A4 (fr) Médicament inhibiteur de cellules cancéreuses et sonde de détection de cellules souches cancéreuses
IL232642A0 (en) A method for characterizing circulating cells and its use in diagnosis
EP2619332A4 (fr) Dosage direct dans le sang destiné à détecter un microarn circulant chez des patients atteints de cancer
IL237411A0 (en) A method for diagnosing and treating cancer that targets molecules expressed in cancer stem cells
EP2880443A4 (fr) Méthodes et compositions pour le diagnostic et le pronostic du cancer du sein
ZA201400892B (en) Detection of prame gene expression in cancer
EP2855705A4 (fr) Méthode de diagnostic du cancer comprenant la détection de la signature de méthylation dans le promoteur htert
EP2594943A4 (fr) Procédé de détection d'une cellule tumorale maligne

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220126